401k Plan data: CARDIAC SCIENCE CORPORATION 401(K) PLAN plan

CARDIAC SCIENCE CORPORATION 401(K) PLAN 401k Plan overview

Plan Name	CARDIAC SCIENCE CORPORATION 401(K) PLAN
Plan identification number	001

CARDIAC SCIENCE CORPORATION 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Participant-directed brokerage accounts provided as an investment option under the plan.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

CARDIAC SCIENCE CORPORATION has sponsored the creation of one or more 401k plans.

Company Name: CARDIAC SCIENCE CORPORATION

Employer identification number (EIN): 811071999

NAIC Classification: 339110

Additional information about CARDIAC SCIENCE CORPORATION

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 3923481

More information about CARDIAC SCIENCE CORPORATION

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CARDIAC SCIENCE CORPORATION 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 ALYSSA WEINAND
001 2016-01-01 MALLORY HOMB
001 2016-01-01

Plan Statistics for CARDIAC SCIENCE CORPORATION 401(K) PLAN

401k plan membership statisitcs for CARDIAC SCIENCE CORPORATION 401(K) PLAN

Measure Date Value
2020: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 266
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 0
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 0
Total of all active and inactive participants 2020-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 0
Number of participants with account balances 2020-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 370
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 2
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 262
Total of all active and inactive participants 2019-01-01 264
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 2
Total participants 2019-01-01 266
Number of participants with account balances 2019-01-01 263
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 2
2018: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 398
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 156
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 213
Total of all active and inactive participants 2018-01-01 369
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 1
Total participants 2018-01-01 370
Number of participants with account balances 2018-01-01 357
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 4
2017: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 390
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 190
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 205
Total of all active and inactive participants 2017-01-01 395
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 3
Total participants 2017-01-01 398
Number of participants with account balances 2017-01-01 353
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 6
2016: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 397
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 189
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 198
Total of all active and inactive participants 2016-01-01 387
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 3
Total participants 2016-01-01 390
Number of participants with account balances 2016-01-01 348
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 7

Measure	Date	Value
2020: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	266
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	0
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	0
Total of all active and inactive participants	2020-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	0
Number of participants with account balances	2020-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	370
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	2
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	262
Total of all active and inactive participants	2019-01-01	264
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	2
Total participants	2019-01-01	266
Number of participants with account balances	2019-01-01	263
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	2
2018: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	398
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	156
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	213
Total of all active and inactive participants	2018-01-01	369
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	1
Total participants	2018-01-01	370
Number of participants with account balances	2018-01-01	357
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	4
2017: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	390
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	190
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	205
Total of all active and inactive participants	2017-01-01	395
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	3
Total participants	2017-01-01	398
Number of participants with account balances	2017-01-01	353
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	6
2016: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	397
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	189
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	198
Total of all active and inactive participants	2016-01-01	387
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	3
Total participants	2016-01-01	390
Number of participants with account balances	2016-01-01	348
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	7

Financial Data on CARDIAC SCIENCE CORPORATION 401(K) PLAN

Measure	Date	Value
2020 : CARDIAC SCIENCE CORPORATION 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-07-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-07-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-07-31	$0
Total income from all sources (including contributions)	2020-07-31	$-2,084,055
Total loss/gain on sale of assets	2020-07-31	$0
Total of all expenses incurred	2020-07-31	$16,027,309
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-07-31	$15,995,763
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-07-31	$0
Value of total assets at end of year	2020-07-31	$0
Value of total assets at beginning of year	2020-07-31	$18,111,364
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-07-31	$31,546
Total interest from all sources	2020-07-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2020-07-31	$8,724
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-07-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-07-31	$8,724
Administrative expenses professional fees incurred	2020-07-31	$22,500
Was this plan covered by a fidelity bond	2020-07-31	Yes
Value of fidelity bond cover	2020-07-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-07-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-07-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-07-31	No
Assets. Other investments not covered elsewhere at end of year	2020-07-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2020-07-31	$66
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-07-31	No
Value of net income/loss	2020-07-31	$-18,111,364
Value of net assets at end of year (total assets less liabilities)	2020-07-31	$0
Value of net assets at beginning of year (total assets less liabilities)	2020-07-31	$18,111,364
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-07-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-07-31	No
Were any leases to which the plan was party in default or uncollectible	2020-07-31	No
Investment advisory and management fees	2020-07-31	$9,046
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-07-31	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-07-31	$16,976,781
Value of interest in common/collective trusts at end of year	2020-07-31	$0
Value of interest in common/collective trusts at beginning of year	2020-07-31	$1,134,517
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-07-31	$-2,094,395
Net investment gain or loss from common/collective trusts	2020-07-31	$1,616
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-07-31	No
Was there a failure to transmit to the plan any participant contributions	2020-07-31	No
Has the plan failed to provide any benefit when due under the plan	2020-07-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-07-31	$15,995,763
Did the plan have assets held for investment	2020-07-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-07-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-07-31	Yes
Opinion of an independent qualified public accountant for this plan	2020-07-31	Disclaimer
Accountancy firm name	2020-07-31	MILLER KAPLAN ARASE LLP
Accountancy firm EIN	2020-07-31	952036255
2019 : CARDIAC SCIENCE CORPORATION 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$6,485,604
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$11,815,398
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$11,787,905
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,297,758
Value of total assets at end of year	2019-12-31	$18,111,364
Value of total assets at beginning of year	2019-12-31	$23,441,158
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$27,493
Total interest from all sources	2019-12-31	$4,540
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$1,137,715
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$1,137,715
Administrative expenses professional fees incurred	2019-12-31	$11,250
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$895,380
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$96,250
Assets. Other investments not covered elsewhere at end of year	2019-12-31	$66
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$65
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$166,798
Administrative expenses (other) incurred	2019-12-31	$590
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$-5,329,794
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$18,111,364
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$23,441,158
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$15,653
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$16,976,781
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$21,508,873
Interest on participant loans	2019-12-31	$4,540
Value of interest in common/collective trusts at end of year	2019-12-31	$1,134,517
Value of interest in common/collective trusts at beginning of year	2019-12-31	$1,835,970
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$3,973,899
Net investment gain or loss from common/collective trusts	2019-12-31	$71,692
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$235,580
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$11,787,905
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	MILLER KAPLAN ARASE LLP
Accountancy firm EIN	2019-12-31	952036255
2018 : CARDIAC SCIENCE CORPORATION 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$600,827
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$6,969,008
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$6,942,718
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,353,936
Value of total assets at end of year	2018-12-31	$23,441,158
Value of total assets at beginning of year	2018-12-31	$29,809,339
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$26,290
Total interest from all sources	2018-12-31	$8,757
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$2,034,984
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$2,034,984
Administrative expenses professional fees incurred	2018-12-31	$10,750
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,112,236
Participant contributions at end of year	2018-12-31	$96,250
Participant contributions at beginning of year	2018-12-31	$181,410
Assets. Other investments not covered elsewhere at end of year	2018-12-31	$65
Assets. Other investments not covered elsewhere at beginning of year	2018-12-31	$2,280,298
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$43,777
Other income not declared elsewhere	2018-12-31	$8,833
Administrative expenses (other) incurred	2018-12-31	$2,415
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-6,368,181
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$23,441,158
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$29,809,339
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$13,125
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$21,508,873
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$25,144,709
Interest on participant loans	2018-12-31	$8,757
Value of interest in common/collective trusts at end of year	2018-12-31	$1,835,970
Value of interest in common/collective trusts at beginning of year	2018-12-31	$2,202,922
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-2,891,656
Net investment gain or loss from common/collective trusts	2018-12-31	$85,973
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$197,923
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$6,942,718
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	MILLER KAPLAN ARASE LLP
Accountancy firm EIN	2018-12-31	952036255
2017 : CARDIAC SCIENCE CORPORATION 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$6,508,657
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$2,562,405
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$2,538,354
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$1,523,898
Value of total assets at end of year	2017-12-31	$29,809,339
Value of total assets at beginning of year	2017-12-31	$25,863,087
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$24,051
Total interest from all sources	2017-12-31	$8,586
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$2,359,924
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$2,359,924
Administrative expenses professional fees incurred	2017-12-31	$10,750
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$1,109,267
Participant contributions at end of year	2017-12-31	$181,410
Participant contributions at beginning of year	2017-12-31	$221,198
Assets. Other investments not covered elsewhere at end of year	2017-12-31	$2,280,298
Assets. Other investments not covered elsewhere at beginning of year	2017-12-31	$2,046,806
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$124,222
Other income not declared elsewhere	2017-12-31	$241,120
Administrative expenses (other) incurred	2017-12-31	$2,130
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$3,946,252
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$29,809,339
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$25,863,087
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$11,171
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$25,144,709
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$21,442,094
Interest on participant loans	2017-12-31	$8,586
Value of interest in common/collective trusts at end of year	2017-12-31	$2,202,922
Value of interest in common/collective trusts at beginning of year	2017-12-31	$2,152,989
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$2,327,160
Net investment gain or loss from common/collective trusts	2017-12-31	$47,969
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$290,409
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$2,538,354
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	MILLER KAPLAN ARASE LLP
Accountancy firm EIN	2017-12-31	952036255
2016 : CARDIAC SCIENCE CORPORATION 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$143,923
Total transfer of assets from this plan	2016-12-31	$3,100
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$2,809,824
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$3,293,996
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$3,261,640
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,366,607
Value of total assets at end of year	2016-12-31	$25,863,087
Value of total assets at beginning of year	2016-12-31	$26,206,436
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$32,356
Total interest from all sources	2016-12-31	$8,730
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$1,137,233
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$1,137,233
Administrative expenses professional fees incurred	2016-12-31	$16,000
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$984,047
Participant contributions at end of year	2016-12-31	$221,198
Participant contributions at beginning of year	2016-12-31	$224,723
Assets. Other investments not covered elsewhere at end of year	2016-12-31	$2,046,806
Assets. Other investments not covered elsewhere at beginning of year	2016-12-31	$1,997,563
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$93,012
Other income not declared elsewhere	2016-12-31	$160,754
Administrative expenses (other) incurred	2016-12-31	$2,086
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$-484,172
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$25,863,087
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$26,206,436
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$14,270
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$21,442,094
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$21,558,196
Interest on participant loans	2016-12-31	$8,730
Value of interest in common/collective trusts at end of year	2016-12-31	$2,152,989
Value of interest in common/collective trusts at beginning of year	2016-12-31	$2,425,954
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$90,489
Net investment gain or loss from common/collective trusts	2016-12-31	$46,011
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$289,548
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$3,261,640
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	MILLER KAPLAN ARASE LLP
Accountancy firm EIN	2016-12-31	952036255

Form 5500 Responses for CARDIAC SCIENCE CORPORATION 401(K) PLAN

2020: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	Yes
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: CARDIAC SCIENCE CORPORATION 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	Yes
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	CARDIAC SCIENCE CORPORATION
Employer identification number (EIN):	811071999
NAIC Classification:	339110

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	3923481